Stoekenbroek, Robert M.
Kastelein, John J. P.
Article History
First Online: 15 June 2017
Competing interests
: J.J.P.K. has received grants and personal fees from Amgen, Gemphire, Madrigal Pharma, Merck, Sharpe and Dohme, Sanofi/Regeneron, and The Medicines Company. R.M.S. declares no competing interests.